Quest Diagnostics Stock - Q2 2026 earnings date confirmed
18.06.2026 - 19:34:28 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:32 CET. Details in the imprint.
Quest Diagnostics (US74834L1008) has confirmed the date for its second-quarter 2026 results. According to a PR Newswire press release dated 06/17/2026, the company will publish earnings and host its conference call on 07/23/2026 before the market opens.
All news and analysis on Quest Diagnostics stock
Stay on top of Quest Diagnostics with the latest earnings dates, regulatory filings and market coverage for this major US diagnostics stock.
What the Q2 date shows
The company plans to release its second-quarter 2026 financial results on 07/23/2026, before the open of US trading, and hold a conference call at 8:30 a.m. Eastern Time that same day, as outlined in the official PR Newswire announcement.
Dial-in numbers for the call include 888-455-0391 for US and Canada and 773-756-0467 for international participants, with the passcode "7895081"; a replay will be available online and by phone until 08/06/2026, according to the release.
Chart picture and recent trading
Quest Diagnostics shares most recently changed hands around $197.76 on the New York Stock Exchange, down roughly 1.6% on the day in the latest available session, based on live quote data from a US market portal.
The same data show an intraday high near $201.04 and a low around $196.50, with opening trades reported at about $200.00 and volume close to 754,000 shares, indicating moderate turnover for the healthcare diagnostics name. Economic Times quote data back up this trading range.
The product behind the stock
Quest Diagnostics generates most of its revenue from diagnostic laboratory testing and related services for physicians, hospitals, employers and insurers, including routine blood work, advanced molecular and genetic tests, and specialized screening programs across the United States.
Where the stock trades today
The shares of Quest Diagnostics (US74834L1008) trade on the New York Stock Exchange at $197.76 as of 06/18/2026, 01:30 IST.
Key facts on Quest Diagnostics stock
- Company: Quest Diagnostics Incorporated
- ISIN: US74834L1008
- WKN: 929921
- Ticker: DGX
- Venue: NYSE
- Price (as of 06/18/2026, 01:30 IST): 197.76 USD
- Market cap: 22,000,000,000 USD (as of 06/18/2026, company and market data rounded)
- Sector / Industry: Health Care / Diagnostic & Research Services
- Index membership: S&P 500
- Next earnings date: 07/23/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
